MAPT and Alzheimer disease: Over the past 25 years, translational studies have supported a hypothetical model describing AD pathophysiology leading to an early build-up of amyloid beta (Aβ) species and plaques inside the brain up to 20–30 years before the subsequent expansion of tau, neuronal loss, and the eventual onset of clinical symptoms [1, 6].